Real-time enrollment status for this schizophrenia clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 3:49 AM UTC
| NCT Number | NCT07114874 |
| Recruiting Status | Recruiting |
| Condition | Schizophrenia |
| Phase | PHASE3 |
| Target Enrollment | 600 participants |
| Active Locations | 49 sites in the US |
| Sponsor | Neurocrine Biosciences |
| Last Updated on CT.gov | June 5, 2026 (Jun 5, 2026) |
As of July 17, 2026: Clinical trial NCT07114874 is currently recruiting participants. This phase3 study for schizophrenia is actively seeking new participants at 49 locations across the United States. The study is sponsored by Neurocrine Biosciences. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07114874 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 49 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07114874 was last updated Jun 5, 2026 (June 5, 2026). HelloStudys verifies this status automatically.